×

BioMarin CEO: Excited about dwarfism drug potential

3:24 PM ET Tue, 23 June 2015

Jean-Jacques Bienaime, Biomarin Pharmaceutical CEO, discusses phase 2 study results from trials of its dwarfism drug, with CNBC's Meg Tirrell.